Skip to main content

Table 3 Associated factors of uric acid clearance on hemodialysis in ESKD

From: Assessment of the efficacy of hemodialysis on uric acid clearance in a sub-Saharan African population at the end stage kidney disease

Variables

Uric acid Clearance

p-value

OR [95% CI]

≥ 65%

<  65%

N (%)

94 (100)

50 (100)

  

Age, n (%)

  < 50 years

47 (50)

26 (52)

0.8

  ≥ 50 years

47 (50)

24 (48)

  

Sex, n (%)

 Men

56 (59.6)

35 (70)

0.2

 Women

38 (40.4)

15 (30)

  

Comorbidities

Excess weight, n (%)

  Yes

25 (26.6)

22 (44)

0.03

0.4 [0.2; 0.9]

  No

69 (73.4)

28 (56)

  

Hypertension, n (%)

  Yes

84 (89.4)

44 (88)

0.8

  No

10 (10.6)

6 (12)

  

Diabetes, n (%)

  Yes

20 (21.3)

13 (26)

0.5

  No

74 (78.7)

37 (74)

  

Gout, n (%)

  Yes

8 (8.5)

8 (16)

0.1

  No

86 (91.5)

42 (84)

  

Underlying nephropathy

Hypertensive nephropathy, n (%)

  Yes

57 (60.6)

31 (62)

0.8

  No

37 (39.4)

19 (38)

  

Diabetic nephropathy, n (%)

  Yes

80 (85.1)

39 (78)

0.2

  No

14 (14.9)

11 (22)

  

Chronic glomerulonephritis, n (%)

  Yes

80 (85.1)

41 (82)

0.6

  No

14 (14.9)

9 (18)

  

Hemodialysis related variables

Blood efflux, n (%)

   < 300 ml/min

49 (52.1)

26 (52)

0.9

   > 300 ml/min

45 (47.9)

24 (48)

  

Interval between dialytic sessions, n (%)

   < 3 days

16 (17)

8 (16)

0.8

   ≥ 3 days

78 (83)

42 (84)

  

Size of the dialysis membrane, n (%)

  FX 10

67 (71.3)

38 (76)

0.5

  FX 8 or FX 5

27 (28.7)

12 (24)

  

Kt/Vurea

   < 1.2

22 (23.4)

38 (76)

0.01

0.1 [0.04; 0.2]

   ≥ 1.2

72 (76.6)

12 (24)